Skip to main content
Download PDF

Effects of Tongmai oral liquid in femoral ateriovenous fistula

BMC Complementary and Alternative Medicine volume 15, Article number: 311 (2015) Cite this article

Abstract

Background

This study was conducted to investigate the protective effect of Tongmai oral liquid on arteriovenous fistula function and to provide an effective method to promote fistula maturation.

Methods

Fifteen female and fifteen male SPF New Zealand rabbits were randomly allocated into 3 groups including control, Aspirin and Tongmai oral liquid groups. A side-to-side femoral arteriovenous fistula was established in each rabbit and then animals were treated with Aspirin or Tongmai oral liquid for 2 weeks. The concentrations of circulating ET-1 and NO were determined before and after operation (on preoperative day, operative day, post-D1, post-D3, post-D7 and post-D15), respectively. Blood flow of the fistula stoma and contralateral artery and vein was determined on the 15th postoperative day. Last, the fistula stoma was dissected to observe patency, thrombosis and adhesion with surrounding tissues.

Results

28 rabbits survived during the surgical process and the following 15-day observational period. Tissue adhesion of arteriovenous fistula with surrounding tissues was improved and fistula thrombosis was reduced by treatment with Tongmai oral liquid. NO concentration decreased to a different extent after vascular surgery. Tongmai oral liquid failed to regulate the equilibrium between NO and ET-1, but it improved blood flow of fistula stoma, as compared to control and Aspirin groups. Blood flow of fistula stoma in the three groups was lower than that of the contralateral femoral artery.

Conclusions

Tongmai oral liquid improved the function of femoral ateriovenous fistula in the rabbit model by increasing blood flow and reducing thrombosis, probably not by regulating the dynamic equilibrium between NO and ET-1.

Peer Review reports

Background

Arteriovenous fistula (AVF) is the first choice for vascular access in hemodialysis patients with chronic kidney diseases. However, it is very difficult to create a functional AVF in senile patients and patients with blood hypertension and diabetes. Moreover, it also costs a lot to maintain AVF and to reduce vascular access-related complications [1]. Because of the frequent failure of maturation of a newly created AVF [2], more and more researchers focus on early fistula maturation.

It has been shown that thrombosis and venous stenosis as a result of neointimal hyperplasia, reduction of blood flow and inadequate dilatation of the venous segment are common causes that contribute to early AVF dysfunction [3–6]. Endothelin-1 (ET-1) and nitric oxide (NO) are mutually antagonistic vasoactive substances secreted by vascular endothelial cell. The dynamic equilibrium of ET-1 and NO is important to maintain normal vascular angiotasis and hemodynamics, and such a balance can regulate endothelial cell proliferation and platelet aggregation [7, 8]. In addition to modulating the contractile state and migration of Vascular Smooth Muscle Cells (VSMC), NO can also inhibits VSMC proliferation [9]. However, the AVF surgery brings injury to endothelial cells and breaks the balance between ET-1 and NO. Besides, chronic kidney disease itself increases neointimal formation and endothelial barrier dysfunction [10]. However, there are no effective methods to improve the early fitula maturation or protect the ateriovenous fistula function so far.

Tongmai oral liquid has been used to treat chronic kidney disease since 1995 in clinical practice of Chinese medicine. It is consisted of radix astragali and radix notoginseng, which are selected based on traditional Chinese medical theory and modern pharmacological studies of Chinese herbal medicine. The main effective ingredients of Tongmai oral liquid are total saponins and total polysaccharides, which can reduce plasma viscosity as well as erythrocyte aggregation index [11]. Our clinical observations showed that it can improve uncomfortable symptoms of patients with glomerulonephritis, such as edema, fatigue, bad appetite, soreness and weakness of waist and knees. And laboratory examinations of the levels of serum creatinine, blood urea nitrogen, 24-h protein excretion, total cholesterol, triglyeride, fibrin degradation product and fibrinogen also decreased to a different extent by treatment with Tongmai oral liquid [12]. Importantly, previous studies showed that Tongmai oral liquid can inhibit platelets’ activation, improve renal hemodynamics, ameliorate hemodialysis patients’ micro-inflammatory state, and improve blood high condensation state [13–16], etc. Therefore, in the present study, we hypothesized that Tongmai oral liquid may potentiate the vascular endothelial cell function and blood flow to promote fistula maturation.

Methods

Consent

Approval was obtained from Animal Experimental Ethics Committee of Guangzhou University of Chinese Medicine prior to performing any procedures on animals.

Experimental animals

The study was carried out in the Laboratory Animal Centre of Guangzhou University of Chinese Medicine. Fifteen female and fifteen male specified-pathogens free (SPF) New Zealand rabbits weighing 2.2-2.4 kg were used (Huadu experimental animal farm, Guangzhou, China, certificate number: 1084322). They were kept in a climate-controlled room with 25 °C and 37 % relative humidity. These rabbits were randomly allocated into 3 groups (control, Aspirin, and Tongmai oral liquid group) according to a random table. Each group consisted of 10 rabbits.

Drugs

Tongmai oral liquid with bath number of 110303 (consisted of Astragalus Membranaceus 3 g and Notoginseng Radix 1 g per 10 ml) were prepared and provided by the Department of Pharmacology in Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China. Aspirin (bath number BJ02005, Bayer Healthcare Co. Ltd) was also provided by the Department of Pharmacology in Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.

Administration method and dosage

Administration dosage was determined according to dose convert coefficient table which is applicable to human and animal dose conversion. The convert coefficient W is 2.3 and the formula is Db (mg/kg) = W × Da (mg/kg) [17]. Namely, the administration dose of B animal is equal to W multiplied by that of A animal. Human’s dosage of Tongmai oral liquid is 60 ml per day, and Aspirin dosage is 100 mg per day.

According to this dosage conversion, solution of Aspirin was made with concentration of 0.77 mg/ml and was administered to rabbits in Aspirin group by 5 ml/kg. The control group was given normal saline (5 ml/kg). The experimental group was given Tongmai oral liquid (5 ml/kg). These drugs were all given by intragastric administration on the day after AVF operation for 14 days.

Establishment of femoral arteriovenous fistula

After randomly allocated, rabbits were anesthetized with pentobarbital sodium (3 % volume fraction, 1 ml/kg) via ear vein injection. Subsequently, they were fixed in a supine position with left leg extended, shaved and sterilely prepared. Through a skin incision 2 cm under the left groin ligament, femoral artery and femoral vein were dissected and exposed. All branches of the femoral artery and vein were ligated. The two vessels were both clamped proximally and distally. A 5–6 mm long incision was made on adjoining sides of the artery and vein respectively and heparin saline (100 IU/ml) was used to syringe the wounds. Then the wounds were saturated with 12–0 atraumatic suture to form a side-to-side femoral artery to vein anastomosis. Next, the vascular clamps were loosed and anastomotic vessels were patent. Finally, the skin was closed with interrupted suture using 4–0 suture and covered with erythromycin ophthalmic ointment to prevent infection.

Determinations of circulating ET-1 and NO concentration

Blood samples (2 ml) were collected from central auricular artery in each group on preoperative day, operative day, post-D1, post-D3, post-D7 and post-D15. ET-1 concentration was determined by using 96 T rabbit ET-1 enzyme linked immunosorbent assay (ELISA) kit (American R&D systems, Batch No.CSB-E06951Rb) [18]. NO concentration was determined by using 96 T rabbit NO ELISA kit (American R&D systems, Batch No.KGE001) [18].

Measurement of blood flow

Blood flow of fistula stoma was determined by using an ultrasonic flow probe (Transonic System, Ithaca, NY) on the 15th postoperative day, following exposure of anastomotic vessels. Blood flow was recorded every 5 s, and the totally observational time was 1 min. Meanwhile, this procedure was also used to test blood flow of the contralateral femoral artery and vein at the same position. The fistula stoma was next dissected to observe patency, thrombosis and adhesion with surrounding tissues. Finally, the animals were executed by euthanasia.

Statistical analysis

Data are reported as mean ± SD. Data were analyzed by one-way ANOVA or repeated measures analysis of variance. P-values of <0.05 were regarded as significant. All calculations were made with SPSS 17.0 software.

Results

Surgical procedure

Two rabbits in the control group died during the surgical procedure. One died of overdose of anesthesia. The other was executed because it regained consciousness during the operation process and was struggled strongly to break the operative vessels. Finally, AVFs were successfully established in 28 rabbits, with 8 in control group, 10 in Aspirin group, and another 10 in Tongmai group. All the 28 rabbits survived during the15-day observational period.

Fistula observations

As shown in Table 1, in Tongmai group, there was one small thrombosis in one fistula stoma with decreased blood flow, while in the other two groups two stomas were completely blocked by thrombosis, with no blood flow. Compared with Aspirin and control groups, tissue adhesion in Tongmai group was significantly reduced by 30 and 60 % respectively. These observations indicated that Tongmai oral liquid could prevent thrombosis and reduce tissue adhesion of AVF with surrounding tissues.

Table 1 Fistula observations in each group on the 15th postoperative day
Full size table

NO and ET-1 concentration measurements

The concentrations of NO and ET-1 were determined before and after operation, as shown in Tables 2 and 3. NO concentrations were significantly different at the indicated time points after surgery (F = 19.267, P = 0.000), both in Aspirin group (F = 1.167, P = 0.005) and Tongmai group (F = 59.258, P = 0.002), except that in control group (F = 1.207, P = 0.326). During the observational period, NO concentration was decreased to a different extent in each group following vascular surgery, which was in accordance with previous literatures [19]. The change of NO concentration was of no significance among three groups (F = 0.817, P = 0.453). Interaction effect existed between different treatment methods and time points (F = 4.299, P = 0.002). After a transient decline (lowest on post-D1), NO concentration increased gradually during the following observational days, as illustrated in Fig. 1.

Table 2 Changes of NO concentration (umol/L, \( \overline{x} \) ± S)
Full size table
Table 3 Changes of ET-1 concentration (pg/ml, \( \overline{x} \) ± S)
Full size table
Fig. 1
figure 1

Change of NO concentrations during the observational period

Full size image

ET-1 levels were significantly different after surgery (F = 2.669, P = 0.025), especially in control group (F = 4.298, P = 0.004), while of no significance in both Aspirin group (F = 1.690, P = 0.156) and Tongmai group (F = 0.659, P = 0.656). The change of ET-1 concentration was not significant among the three groups (F = 3.179, P = 0.059). Interaction effect existed between different treatment methods and time points (F = 2.274, P = 0.018). After surgery, ET-1 levels in Tongmai and control groups increased to a peak on post-D1 and post-D7 respectively, and subsequently decreased in both groups, as demonstrated in Fig. 2.

Fig. 2
figure 2

Change of ET-1 concentrations during the observational period

Full size image

Blood flow measurements

Blood flow of fistula stoma, contralateral femoral artery and vein was measured on the 15th postoperative day. Fistula blood flow was significantly lower than that of the contralateral femoral artery in the same group (P < 0.05). And this outcome was mildly improved by Tongmai oral liquid although there was no significance among three groups (F = 1.668, P = 0.209). On the other hand, blood flow of the contralateral femoral artery was at similar level among three groups (P > 0.05), indicating that Aspirin and Tongmai oral liquid did not play a role in the healthy vessel (Table 4).

Table 4 Blood flow measurements on the 15th postoperative day
Full size table

Discussion

Thrombosis and venous stenosis as a result of neointimal hyperplasia are leading causes for AVFs dysfunction [3, 4]. Mechanisms of neointimal hyperplasia are related to endothelial cell damage, inflammation, decrease of NO synthesis, migration of myofibroblasts, oxidative stress and laminar fluid shear stress [20]. In addition, upregulation of transforming growth factor beta1 (TGF-beta1) plays an important role in the process of neointimal hyperplasia by promoting fibroblasts proliferation [21, 22] and stimulating adventitial fibroblasts transforming to myofibroblasts and migration [23]. Besides, surgical trauma to the vasa vasorum of the outflow vein can promote adventitial myofibroblasts migration as well as lead to neointimal hyperplasia [24]. Of note, our previous studies showed that Tongmai oral liquid can suppress production of TGF-beta1 in diabetic nephropathy murine models and mesangial proliferative glomerulonephritis rats [25, 26]. Therefore, we hypothesized that Tongmai oral liquid is applied for improving AVFs dysfunction.

In traditional Chinese medical theory, the complex process of neointimal hyperplasia and stenosis is, at least in part, due to Qi-deficiency and the subsequent blood stasis. Qi-deficiency and blood stasis exists in the progression of chronic kidney disease [27], and the surgical procedure of establishing an arteriovenous fistula aggravates injuries of blood vessels and Qi activities. Modern studies of Chinese medicine consider blood stasis as blood circulation obstacle, such as thrombosis and platelet aggregation [28], which is closely related to endothelial cell injury, high blood viscosity and inflammatory response [29–31]. Tongmai oral liquid was made from several Chinese herbals (Table 5) which can relieve blood stasis via nourishing Qi. For example, the pharmacological studies have shown that both astragali and radix notoginseng can improve hemorrheology, anti-platelet aggregation, and promote fibrinolysis to reduce thrombosis [32–35]. Moreover, we previously reported that Tongmai oral liquid is able to ameliorate hemodialysis patients’ micro-inflammatory state and inhibit platelets’ activation [13, 15]. Furthermore, as shown in Table 4, Tongmai oral liquid could increase blood flow of fistula stoma, compared with Aspirin and control group (8.80 ± 4.24 vs 6.00 ± 3.49 vs 6.00 ± 3.89 ml/min). In rabbit AVF model, 2 weeks’ treatment of Tongmai oral liquid could improve tissue adhesion around the AVF and reduce thrombosis. As shown in Table 1, tissue adhesion in Tongmai group was significantly reduced by 30 and 60 % respectively compared with Aspirin and control groups. Aspirin treatment served as positive control, since it is an effective antiplatelet aggregation drug to prevent fistula thrombosis [36] and improve AVF survival [37]. Aspirin’s effect of anti-thrombosis seemed not to be effective enough in this model, which could be due to reduction of blood flow. Altogether, our results strongly suggest that Tongmai oral liquid can promote a well functional AVF through, at least in part, increasing blood flow as well as suppressing neointimal hyperplasia.

Table 5 Components of Tongmai Oral Liquid (per 10 ml)
Full size table

It is well known that ET-1 is a powerful vasoconstrictor while NO is a potent vasodilative substance [7]. The impairment of the balance between NO and ET-1 can induce endothelial cell dysfunction [8]. To determine if Tongmai oral liquid could promote blood circulation by improving endothelial cell function, concentrations of NO and ET-1 were evaluated in our model studied. Unfortunately, the data showed that Tongmai oral liquid and Aspirin only slightly reversed the downward trend of NO after operation, which was of no statistical significance.

Interestingly, in our rabbit AVF models, blood flow of fistula stoma was generally low in each group, even lower than that of the contralateral femoral artery which is contrary to clinical practice and other animal AVF models [38–43]. Though reduction of fistula blood flow is frequently in the period of fistula maturation and maintains, both clinical and experimental studies demonstrated increased blood flow of fistula and cardiac output as well as decreased systematic vascular resistance following the creation of AVF. Since it is a newly created AVF with successful surgical procedure, the following aspects are possibly to be considered for contributing to low blood flow: 1) Surgery itself is an injurious strike to normal blood vessel anatomy to cause pathological changes of blood milieu internae and hemodynamics. 2) Stenosis of fistula stoma and out-flow vein tract caused by neointimal hyperplasia and vascular remodeling. A previous study in a rodent femoral artery to vein fistula [44] demonstrated apparently polypoid neointimal hyperplasia at the anastomosis venous lesion on the 14th day after surgery. 3) Underlying thrombosis. 4) The observational period was too short for a fistula to maturate. Therefore, it is worth doing the further studies in our model established to clarify all the questions raised, especially to detect the role of Tongmai oral liquid in venous stenosis.

There are also some limitations in our study. Since Tongmai oral liquid has special colour and taste which can be distinguished from other drugs easily by the experimenter, double blind method is difficult to implement during the experimental process. Besides, though sample size of the study was determined based on experimental estimation, it still seems not sufficient enough. We plan to expand sample size and try to overcome the technical problem of implementing blinding method in our further study.

Conclusions

In conclusion, Tongmai oral liquid improved the function of femoral AVF in the rabbit model by increasing blood flow and reducing thrombosis. The mechanisms of this protective effect are probably not relevant to regulating the dynamic equilibrium between NO and ET-1. Further studies are needed to examine the role of Tongmai oral Liquid in venous stenosis in rabbit AVF model.

Abbreviations

AVF:

Ateriovenous fistula

ELISA:

Enzyme linked immunosorbent assay

ET-1:

Endothelin-1

NO:

Nitric oxide

SPF:

Specified-pathogens free

TGF-beta1:

Transforming growth factor beta1

VSMC:

Vascular smooth muscle cells

References

  1. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996;7(4):523–35.

    CAS  PubMed  Google Scholar 

  2. Vachharajani TJ. Diagnosis of arteriovenous fistula dysfunction. Semin Dial. 2012;25(4):445–50.

    Article  PubMed  Google Scholar 

  3. Campos RP, Do NM, Chula DC, Do Nascimento DE, Riella MC. Stenosis in hemodialysis arteriovenous fistula: evaluation and treatment. Hemodial Int. 2006;10(2):152–61.

    Article  PubMed  Google Scholar 

  4. Roy-Chaudhury P, Arend L, Zhang J, Krishnamoorthy M, Wang Y, Banerjee R, et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis. 2007;50(5):782–90.

    Article  PubMed  Google Scholar 

  5. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int. 2002;62(4):1109–24.

    Article  PubMed  Google Scholar 

  6. Nassar GM, Nguyen B, Rhee E, Achkar K. Endovascular treatment of the “failing to mature” arteriovenous fistula. Clin J Am Soc Nephrol. 2006;1(2):275–80.

    Article  PubMed  Google Scholar 

  7. Liu QX. Significance of NO and endothelin interactions in cardiovascular disease [In Chinese]. Chin J Microcirc. 1997;01:46–9.

    Google Scholar 

  8. Wang HT, Ji KG, Wang X. Progression of endothelial function in cardiovascular disease [In Chinese]. Guangming J Chin Med. 2009;06:1193–5.

    Google Scholar 

  9. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol. 1994;267:C1405–13.

    CAS  PubMed  Google Scholar 

  10. Liang A, Wang Y, Han G, Truong L, Cheng J. Chronic kidney disease accelerates endothelial barrier dysfunction in a mouse model of an arteriovenous fistula. Am J Physiol Renal Physiol. 2013;304(12):1413–20.

    Article  Google Scholar 

  11. Lin HQ. Studies on the pharmacologic substance basis of Tongmai oral liquid [In Chinese]. MM thesis. Guangzhou: Guangzhou University of Chinese Medicine, Chinese Herbal Medicine Department; 2005.

  12. Yang NZ, Wang LX, Lin QZ, Mao W, Bao Y. Effect of Tongmai oral liquid in chronic nephritis of Qi-dificiency and blood stasis type: a clinical study of 32 cases [In Chinese]. J New Chinese Med. 2003;01:19–21.

    Google Scholar 

  13. Wang J. Effect of Sanqi Oral Liquid on platelet activity of diabetes nephrology [In Chinese]. PhD thesis. Guangzhou: Guangzhou University of Chinese Medicine, Traditional Chinese Internal Medicine Department; 2011.

  14. Chen Q, Shen Q, Xie XY, Shen JH, Wang LX, Dang H. Effect of Tongmai Oral Liquid on hemodynamics of patients with chronic glomerular nephritis [In Chinese]. J New Chinese Med. 2011;03:42–3.

    Google Scholar 

  15. Lin QZ, Fan LM, Huang J, Bao K, Li F, Wu XQ, et al. Effect of Tongmai Oral Liquid in microinflammation status in patients with hemodialysis [In Chinese]. Chin J Integr Tradit West Nephrol. 2010;05:437–9.

    Google Scholar 

  16. Wang LX, Yang NZ. Effect of Tongmai Oral Liquid to hemorrheology of patients with chronic glomerular nephritis [In Chinese]. Heilongjiang J Tradit Chin Med. 1997;04:47–8.

    CAS  Google Scholar 

  17. Shi XY. Methodology of medical animal experiments [In Chinese]. Beijing: People’s Medical Publishing House; 1980.

    Google Scholar 

  18. Ghanem AA, Elewa AM, Arafa LF. Endothelin-1 and nitric oxide levels in patients with glaucoma. Ophthalmic Res. 2011;46(2):98–102.

    Article  CAS  PubMed  Google Scholar 

  19. Gokce N, Keaney JJ, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function:a prospective study. Circulation. 2002;105(13):1567–72.

    Article  PubMed  Google Scholar 

  20. Hu PP, Yang F, Wang YZ. Dynamic study progress of neointimal hyperplasia mechanisms in AVF [In Chinese]. Chin Jf Blood Purif. 2011;10(10):564–6.

    Google Scholar 

  21. Stracke S, Konner K, Kostlin I, Friedl R, Jehle PM, Hombach V, et al. Increased expression of TGF-beta1 and IGF-1 in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int. 2002;61:1011–9.

    Article  CAS  PubMed  Google Scholar 

  22. Jiang D, Jiang Z, Han F, Zhang Y, Li Z. HGF suppresses the production of collagen type III and alpha-SMA induced by TGF-beta1 in healing fibroblasts. Eur J Appl Physiol. 2008;103:489–93.

    Article  CAS  PubMed  Google Scholar 

  23. Subramanian SV, Polikandriotis JA, Kelm Jr RJ, David JJ, Orosz CG, Strauch AR. Introduction of vascular smooth muscle alpha-actin gene transcription in transforming growth factor beta1 activated myofibroblasts mediated by dynamic interplay between the Pur repressor proteins and Sp1/Smad coactivators. Mol Biol Cell. 2004;15:4532–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Yang B, Janardhanan R, Vohra P, Greene EL, Bhattacharya S, Withers S, et al. Adventitial transduction of lentivirus-shRNAVEGF-A in arteriovenous fistula reduces venous stenosis formation. Kidney Int. 2014;85(2):289–306.

    Article  CAS  PubMed  Google Scholar 

  25. Fan P, Yang NZ. Effect of Tongmai oral liquid to real pathology and TGF-beta1 in a diabetic nephropathy murine model [In Chinese]. J Guangzhou Univ Tradit Chin Med. 2008;06:514–8.

    Google Scholar 

  26. Wang LX, Duan XJ, Yang NZ, Yang HF, Ou RM, Han L, et al. Effects of Tongmai oral liquid to tubulointerstitial lesion in primary nephritis [In Chinese]. Liaoning J Tradit Chin Med. 2011;04:764–7.

    CAS  Google Scholar 

  27. Wang LX. Chronic renal failure syndromes distribution and discussion on the mechanism of Yiqi Huoxue Juandu therapy [In Chinese]. PhD thesis. Guangzhou: Guangzhou University of Chinese Medicine, Traditional Chinese Internal Medicine Department; 2006.

  28. Li JD. The connotation of modern pathology of blood stasis [In Chinese]. Chin J Basic Med Chin Med. 1998;4:21.

    Google Scholar 

  29. Li X, Jiang P. Endothelial cell injury and blood stasis [In Chinese]. Chin J Integr Med. 2000;02:75–7.

    Google Scholar 

  30. Wang J, Yao KW. Research progression and reflection of essence of blood stasis syndrome [In Chinese]. China J Tradit Chin Med Pharm. 2003;08:490–3.

    Google Scholar 

  31. Chen KJ, Li LD, Weng WL. Research of blood stasis syndrome and activating blood to remove blood stasis [In Chinese]. Chin J Integr Med Cardio-Cerebrovascular Dis. 2005;01:1–2.

    Article  Google Scholar 

  32. Yang JQ, He HB. Pharmacological research progression of Astragalus [In Chinese]. J Med Theory Pract. 2010;02:148–50.

    Google Scholar 

  33. Li JH. Pharmacological research of Astragalus [In Chinese]. J Liaoning Univ Tradit Chin Med. 2009;04:188–9.

    CAS  Google Scholar 

  34. He K. Pharmacological research progression of radix notoginseng [In Chinese]. Chin J Ethnomed Ethnopharmacy. 2011;06:21–3.

    Google Scholar 

  35. He J. Pharmacological effect and research progression of radix notoginseng [In Chinese]. Tianjin Pharmacy. 2004;05:58–60.

    Google Scholar 

  36. Li ZX, Li J. Aspirin reduces fistula thrombosis in patients with uremia [In Chinese]. J Modern Med Health. 2012;16:2479–80.

    Google Scholar 

  37. Hasegawa T, Elder SJ, Bragg-Gresham JL, Pisoni RL, Yamazaki S, Akizawa T, et al. Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol. 2008;3(5):1373–8.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kang L, Yamada S, Hernandez MC, Croatt AJ, Grande JP, Juncos JP, et al. Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula. Am J Physiol Renal Physiol. 2011;301(4):F845–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Manning E, Skartsis N, Orta AM, Velazquez OC, Liu ZJ, Asif A, et al. A new arteriovenous fistula model to study the development of neointimal hyperplasia. J Vasc Res. 2012;49(2):123–31.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Langer S, Heiss C, Paulus N, Bektas N, Mommertz G, Rowinska Z, et al. Functional and structural response of arterialized femoral veins in a rodent AV fistula model. Nephrol Dial Transplant. 2009;24(7):2201–6.

    Article  PubMed  Google Scholar 

  41. Li J, Liu H, Zhu XP, Peng YM, Liu FY. Dynamic observation of Hemodynamics to patients treated with hemodialysis suffered with arteriovenous fistula [In Chinese]. J Mod Med. 2003;15:32–3.

    Google Scholar 

  42. Zheng DW, Liu GH, Ye RG, Xie YH. Effect of AVF blood flow on cardiac function of hemodialysis patients [In Chinese]. Chin J Integr Tradit Western Nephrology. 2004;06:328–9.

    Google Scholar 

  43. Saad TF. Management of the immature autogenous arteriovenous fistula. Vascular. 2010;18(6):316–24.

    Article  PubMed  Google Scholar 

  44. Hua S, Ye CY, Dong ZY, Gao X, Ji CC, Fu LL, et al. A rat model of autogenous internal arteriovenous fistula and the experimental study on internal fistula stenosis [In Chinese]. Chin J Blood Purif. 2009;6:322–5.

    Google Scholar 

Download references

Acknowledgements

This study was supported by Natural Science Fund of Guangdong Province (No. 8451040701001598).

Author information

Authors and Affiliations

  1. Department of Nephrology, The Second Affiliated Hospital, Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), No.111 of Dade Road, Guangzhou, 510120, China

    Pei-Ling Su, Kun Bao, Han-Guo Peng, Wei Mao, Guan-Su Wang, Ni-Zhi Yang, Wen-Jia Geng, Yi-Qun Lin & Xi-Na Jie

  2. Department of Nephrology, The Third Affiliated Hospital, Guangxi University of Chinese Medicine (Liuzhou traditional Chinese Medical Hospital), No.32 of Jiefang Road, Liuzhou, 545001, China

    Pei-Ling Su

  3. Jiangmen Xinhui District Hospital of Chinese Medicine, No.47 of Huimin Road, Jiangmen, 529100, China

    Han-Guo Peng

Authors
  1. Pei-Ling Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kun Bao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Han-Guo Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wei Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guan-Su Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ni-Zhi Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wen-Jia Geng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yi-Qun Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xi-Na Jie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kun Bao.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

KB designed the study and coordinated the experiments and drafted the manuscript. PLS drafted the manuscript. HGP and GSW carried out the animal study. WM and NZY participated in the design and data analysis of the experiment. WJG and XNJ participated in the determination of ET-1 and NO. YQL involved in the blood flow determination. All authors read and approved the final manuscript.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Su, PL., Bao, K., Peng, HG. et al. Effects of Tongmai oral liquid in femoral ateriovenous fistula. BMC Complement Altern Med 15, 311 (2015). https://doi.org/10.1186/s12906-015-0844-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12906-015-0844-8

Keywords

  • Tongmai oral liquid
  • Early fistula maturation
  • Hemodialysis

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us